No Data
No Data
Home Healthcare Inflation Is Stubbornly High -- WSJ
With 32% Ownership, Bioventus Inc. (NASDAQ:BVS) Has Piqued the Interest of Institutional Investors
Top SA Quant-rated Medical Devices Stocks as Technicals Look Strong
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CCORF Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $15
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating